Search Results - Sharon Lu
- Showing 1 - 4 results of 4
-
1
Comparative analysis of PD‐1 target engagement of dostarlimab and pembrolizumab in advanced solid tumors using ex vivo IL‐2 stimulation data by Daren Austin, Murad Melhem, Yash Gandhi, Sharon Lu, Sandra Visser
Published 2023Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
2
A competitive ligand-binding assay for the detection of neutralizing antibodies against dostarlimab (TSR-042) by Xiaolong Tom Zhang, Hong Chen, Weiping Shao, Zhongping John Lin, Murad Melhem, Sharon Lu
Published 2021Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
3
A bridging assay for detection and characterization of anti-drug antibodies to dostarlimab, a new anti-PD-1 therapeutic monoclonal antibody by Marilyn Patterson, Lee Anne Beausang, Bonita Rup, Ronald R. Bowsher, Kim Krug, Murad Melhem, Sharon Lu
Published 2021Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
4
Preclinical characterization of dostarlimab, a therapeutic anti-PD-1 antibody with potent activity to enhance immune function in in vitro cellular assays and in vivo animal models by Sujatha Kumar, Srimoyee Ghosh, Geeta Sharma, Zebin Wang, Marilyn R. Kehry, Margaret H. Marino, Tamlyn Y. Neben, Sharon Lu, Shouqi Luo, Simon Roberts, Sridhar Ramaswamy, Hadi Danaee, David Jenkins
Published 2021Call Number: Loading…Connect to this object online.
Located: Loading…
Book